Travaux scientifiques

Doç. Dr. Aslan Aykut

60 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261480211 PMID 42630057 Texte intégral en libre accèsSource : OpenAlex

  2. Long‐Term Peripheral Vitreoretinal Interface Abnormalities of Retinopathy of Prematurity: Ultra‐Wide Field Optical Coherence Tomography Findings

    Clinical & Experimental Ophthalmology, 2026

    DOI 10.1111/ceo.70106 PMID 41846489 Source : ORCID

  3. Diagnostic Utility of Peripheral Blood MYD88 L265P Testing in Vitreoretinal Lymphoma

    Genes, 2026

    DOI 10.3390/genes17101172 PMID 42938287 Texte intégral en libre accèsSource : ORCID

  4. Comparison of Optical Coherence Tomography Biomarkers in Nonproliferative and Proliferative Diabetic Retinopathy: Marmasia Study Group Report No. 2

    Turkish journal of ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.24196 PMID 42928578 Texte intégral en libre accèsSource : Europe PMC

  5. Multimodal Imaging Features of Bilateral Diffuse Uveal Melanocytic Proliferation: A Systematic Review of 82 Patients

    Ocular Oncology and Pathology, 2026

    DOI 10.1159/000550536 PMID 41835104 Texte intégral en libre accèsSource : OpenAlex

  6. Does ‘Turkish ophthalmology’ need clarification? What truly constitutes our field?

    European eye research, 2026

    DOI 10.14744/eer.2025.57441 Texte intégral en libre accèsSource : OpenAlex

  7. Reply

    Retina, 2026

    DOI 10.1097/iae.0000000000004890 PMID 42212945 Source : OpenAlex

  8. Intravitreal nintedanib attenuates proliferative vitreoretinopathy in a mouse model: Efficacy, safety, and mechanistic insights

    Experimental Eye Research, 2026

    DOI 10.1016/j.exer.2026.111115 PMID 42264059 Source : OpenAlex

  9. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

    Eye, 2025

    DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  10. Incontinentia Pigmenti: Ocular Genetic Studies

    Güncel Retina Dergisi (Current Retina Journal), 2025

    DOI 10.37783/crj-0519 Texte intégral en libre accèsSource : ORCID

  11. TREATMENT OF CHOROIDAL METASTASIS WITH COMBINED PHOTODYNAMIC THERAPY AND BEVACIZUMAB AND COMPARISON WITH PHOTODYNAMIC THERAPY ALONE

    Retina, 2025

    DOI 10.1097/iae.0000000000004566 PMID 40577639 1 citation (Europe PMC) Source : ORCID

  12. Photodynamic therapy in ocular oncology: A bibliometric analysis (1987–2024)

    Photodiagnosis and Photodynamic Therapy, 2025

    DOI 10.1016/j.pdpdt.2025.104654 PMID 40447061 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  13. Real-Life Comparison of Off-Label Intravitreal Biosimilar Bevacizumab-awwb and Reference Bevacizumab in Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2025

    DOI 10.31067/acusaglik.1528212 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  14. Role of PPV in Advanced Retinal Hemangioblastoma—A Systematic Review

    International Ophthalmology Clinics, 2025

    DOI 10.1097/iio.0000000000000588 PMID 40993903 Source : OpenAlex

  15. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group

    European Journal of Ophthalmology, 2024

    DOI 10.1177/11206721241280737 PMID 39234628 Source : OpenAlex

  16. One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13

    Seminars in Ophthalmology, 2024

    DOI 10.1080/08820538.2024.2324450 PMID 39087722 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  17. Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

    International Ophthalmology, 2024

    DOI 10.1007/s10792-024-03251-1 PMID 39317810 Source : OpenAlex

  18. Belzutifan as the first-line treatment for a challenging von Hippel-Lindau–related retinal hemangioblastoma: successful treatment of a case and review of the literature

    Canadian Journal of Ophthalmology, 2024

    DOI 10.1016/j.jcjo.2024.05.025 PMID 39043253 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  19. ChatGPT versus strabismus specialist on common questions about strabismus management: a comparative analysis of appropriateness and readability

    Marmara Medical Journal, 2024

    DOI 10.5472/marumj.1571218 4 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  20. Exploring the Potential of Code-Free Custom GPTs in Ophthalmology: An Early Analysis of GPT Store and User-Creator Guidance

    Ophthalmology and Therapy, 2024

    DOI 10.1007/s40123-024-01014-w PMID 39141071 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  21. Diagnosing retinal disorders with artificial intelligence: the role of large language models in interpreting pattern electroretinography data

    Journal of Health Sciences and Medicine, 2024

    DOI 10.32322/jhsm.1506378 4 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  22. The First Look at Code-Free Custom GPTs in Medicine: An Ophthalmology Perspective (Preprint)

    2024

    DOI 10.2196/preprints.59729 Source : ORCID

  23. Turkish Retinoblastoma Research: A Bibliometric Analysis (1966-2024)

    Turkish journal of ophthalmology, 2024

    DOI 10.4274/tjo.galenos.2024.43247 PMID 39463168 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  24. NOVEL MULTIMODAL IMAGING IN BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION AND CHANGE IN THE FINDINGS DURING FOLLOW-UP AND TREATMENT

    Retina, 2024

    DOI 10.1097/iae.0000000000004361 PMID 39652829 4 citations (OpenAlex) Source : OpenAlex

  25. Turkish uveal melanoma research: A bibliometric analysis (1987–2024)

    European eye research, 2024

    DOI 10.14744/eer.2024.42714 Texte intégral en libre accèsSource : OpenAlex

  26. Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

    Turkish Journal of Ophthalmology, 2023

    DOI 10.4274/tjo.galenos.2023.56249 PMID 38126607 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  27. Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy

    Ophthalmic and Physiological Optics, 2023

    DOI 10.1111/opo.13187 PMID 37318037 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  28. Staphylococcus hominis: a rare cause of endophthalmitis

    Arquivos brasileiros de oftalmologia, 2023

    DOI 10.5935/0004-2749.20230035 PMID 35319646 5 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  29. Dysfunctional personality beliefs and psychopathology in patients with central serous chorioretinopathy

    Journal Français d Ophtalmologie, 2023

    DOI 10.1016/j.jfo.2023.05.032 PMID 37919151 4 citations (OpenAlex) Source : OpenAlex

  30. A Useful Method for the Practice of Pneumatic Retinopexy: Slit-Lamp Laser Photocoagulation through the Gas Bubble

    Journal of Personalized Medicine, 2023

    DOI 10.3390/jpm13050741 PMID 37240912 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  31. Gerçek Yaşamda Diyabetik Maküla Ödemi Hastalarında Dış Retina Katman Bozukluklarının Anti-VEBF Tedavinin 12. Ay Görsel Sonuçlarına Etkisi: MARMASIA ÇALIŞMA Grubu Rapor No:15

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  32. Gerçek yaşamda Diyabetik Maküla Ödemi Hastalarında İntravitreal Aflibercept ve Ranibizumab Tedavisinin ilk 12 ve 24 Aylık Sonuçları: MARMASIA Çalışma Grubu Rapor No.6

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  33. Gerçek Yaşamda Diyabetik Maküler Ödem Tedavisinde Anti-Vasküler Büyüme Faktörü Tedavisi Alan Hastalarda Yükleme Dozu Tamamlanma Süresinin Tedavi Sonucuna Etkileri: MARMARASIA Çalışma Grubu Rapor No. 5

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  34. Gerçek Yaşamda Diyabetik Maküla Ödeminin Optik Koherans Tomografi Paternlerinin İntravitreal Enjeksiyon Tedavisine Yanıtılarının Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No.13

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  35. Gerçek Yaşamda Nonproliferatif ve Proliferatif Diyabetik Retinopatili Gözlerde Optik Koherens Tomografi Belirteçlerinin Karşılaştırılması: MARMASIA Çalışma Grubu Rapor No. 2

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  36. Gerçek Yaşamda Diyabetik Maküla Ödemi Olan Hastalarda Vitreomaküler Arayüzey Hastalıklarının anti-VEBF Tedavisinde Etkisinin Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No. 10

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  37. Gerçek Yaşamda Diyabetik Maküla Ödemi Tedavisinde Arka Hyaloid Ayrışmasının Etkisi: MARMASIAÇalışma Grubu Rapor No. 11

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  38. Gerçek Yaşamda Pars Plana Vitrektomi Geçirmiş Gözlerde Diyabetik Maküler Ödem Tedavisinde İntravitreal Aflibercept ve Ranibizumab Tedavisinin Etkinliğinin Kısa Dönemde Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No. 12

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  39. Gerçek Yaşamda Diyabetik Kistoid Maküla Ödemli Hastalarda Aflibecept ve Ranibizumab Tedavisinin Kist Büyüklüğüne Olan Etkisinin Karşılaştırılması: MARMASIA Çalışma Grubu Rapor No.16

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  40. Gerçek Yaşamda Diyabetik Maküla Ödemi Olan Hastalarda Erken ve Geç Dönem Anti-VEBF Yanıtı ve OKT Bulgularının İlişkisi: MARMASIA Çalışma Grubu Rapor No. 4

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  41. Gerçek Yaşamda Aflibercept ile Tedavi Edilen Diyabetik Maküla Ödemi Hastalarında İlk 12 Ayda Yapılan Enjeksiyon Sayısının 12. ve 24. Ay Görsel Sonuçlarına Etkisi: MARMASIA Çalışma Grubu Rapor No. 3

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  42. Gerçek Yaşamda İyi Görme Keskinliğine Sahip Diyabetik Maküla Ödemli Hastalarda 12 Aylık Tedavi Sonuçları: MARMASIA Çalışma Grubu Rapor No:8

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  43. Gerçek Yaşamda Diyabetik Maküla Ödemi Tedavisi: MARMASIA Çalışma Grubu Rapor No. 1

    Kocaeli Üniversitesi - AVESİS, 2022

    Source : OpenAlex

  44. Subthreshold Photocoagulation, Laser Endpoint Management Based on Optical Coherence Tomography Angiography in Cases of Diabetic Macular Edema Refractory to Anti-VEGF

    Klinische Monatsblätter für Augenheilkunde, 2022

    DOI 10.1055/a-1792-3009 PMID 35453154 6 citations (Europe PMC) Source : OpenAlex

  45. Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy

    Ophthalmologica, 2022

    DOI 10.1159/000523704 PMID 35249031 5 citations (Europe PMC) Source : OpenAlex

  46. Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy

    Cutaneous and Ocular Toxicology, 2022

    DOI 10.1080/15569527.2022.2068150 PMID 35579866 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  47. Effect of the pandemic on surgical procedures in a tertiary care hospital: A retrospective review

    Turkish Journal of Surgery, 2022

    DOI 10.47717/turkjsurg.2022.5256 PMID 36846060 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  48. Intestinal perforation after intravitreal low dose ranibizumab injection for the treatment of type 1 retinopathy of prematurity: A case report

    European Journal of Ophthalmology, 2022

    DOI 10.1177/11206721221099249 PMID 35491668 4 citations (OpenAlex) Source : OpenAlex

  49. Choroidal vascularity index changes during the Valsalva manoeuvre in healthy volunteers

    Ophthalmic and Physiological Optics, 2022

    DOI 10.1111/opo.12935 PMID 34913506 10 citations (Europe PMC) Source : ORCID

  50. Etiological and Clinical Characteristics of Anterior Uveitis Cases in a Tertiary Hospital in Istanbul

    Kocaeli Medical Journal, 2022

    DOI 10.5505/ktd.2022.51447 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex